Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06241430 · ClinicalTrials.gov registry record · NA
The CardioClip Study
A NA study of Heart Failure With Reduced Ejection Fraction and Mitral Regurgitation, sponsored by Columbia University.
- Recruiting
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT06241430: Recruiting NA study of Heart Failure With Reduced Ejection Fraction and Mitral Regurgitation, sponsored by Columbia University.
NCT06241430 is a NA study of Heart Failure With Reduced Ejection Fraction and Mitral Regurgitation that is actively recruiting participants, run by Columbia University. The registered enrollment target is 60 participants, below the 3,964-participant average among 27 other Heart Failure With Reduced Ejection Fraction trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06241430, a NA study of Heart Failure With Reduced Ejection Fraction and Mitral Regurgitation, is actively recruiting participants, sponsored by Columbia University.
- RECRUITING
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
The CardioClip study is exploring the use of a wireless sensor to monitor pressure in the pulmonary artery. This sensor is inserted much like the mTEER procedure, a non-surgical method through a vein in the groin. The investigators want to find out if the sensor, by constantly sending information about heart function, can help improve patient outcomes. This means doctors could adjust medications based on real-time pressure changes detected by the sensor. The results from this study will help pave the way for future trials, asking if using these wireless sensors could benefit people with valve disease and heart failure.
Primary Outcome
The Kansas City Cardiomyopathy Questionnaire (KCCQ) is a 23-item self-administered questionnaire developed to independently measure the patient's perception of their health status, which includes heart failure symptoms, impact on physical and social function, and how their heart failure impacts their quality of life (QOL) within a 2-week recall period. To facilitate interpretation, all scores are represented on a 0-to-100-point scale, where lower scores represent more severe symptoms and/or limi
Conditions Studied
Interventions
- DEVICE CardioMEMS
Study Locations (1)
New York
- Columbia University Irving Medical Center / NewYork-Presbyterian Hospital - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2024-12-18 |
| Est. Completion | 2027-11 |
| Phase | NA |
What NCT06241430 shows while recruiting
NCT06241430 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 3,964-participant average among 27 other Heart Failure With Reduced Ejection Fraction trials with a reported enrollment target (98% lower).
The record links to 2 conditions, with Heart Failure With Reduced Ejection Fraction appearing as the primary indexed condition, and to 1 intervention - of which CardioMEMS is the first listed.
NCT06241430 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT06241430 about?
NCT06241430 is a clinical study titled "The CardioClip Study". The CardioClip study is exploring the use of a wireless sensor to monitor pressure in the pulmonary artery. This sensor is inserted much like the mTEER procedure, a non-surgical method through a vein in the groin. The investigators want to find out if the sensor, by constantly sending information ab...
What is the current status of trial NCT06241430?
This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2024-12-18. Estimated completion is 2027-11.
What conditions does trial NCT06241430 study?
This clinical trial studies the following conditions: Heart Failure With Reduced Ejection Fraction, Mitral Regurgitation.
What interventions are being tested in trial NCT06241430?
The interventions under investigation include: CardioMEMS (DEVICE).
Who is sponsoring clinical trial NCT06241430?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06241430 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Failure With Reduced Ejection Fraction
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06241430's enrollment target sits among peer trials
60 20th of 27 higher than 8 of 27 other Heart Failure With Reduced Ejection Fraction trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Heart Failure With Reduced Ejection Fraction trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Pilot Study Lp299v Supplementation in Chronic Heart Failure
RECRUITING · NA
-
PRIME HFrEF: Novel Exercise for Older Patients With Heart Failure With Reduced Ejection Fraction
RECRUITING · NA
-
An Early Feasibility Study Evaluation of an Implant Free Interatrial Shunt to Improve Heart Failure
RECRUITING · NA
-
Home-Based Cardiac Rehabilitation for Patients With Heart Failure
RECRUITING · NA
-
Implementation and Interaction of Clinician And Patient-facing Tools Aiming to Intensify Neurohormonal Medicines for Heart Failure
RECRUITING · NA
-
Comparative Effectiveness of Prophylactic ICD Versus Non-ICD Therapy
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI